References
- World Health Organization. Rolling updates on coronavirus disease (COVID-19). 2020 Jul 31 [cited 2020 Jul 31]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
- World Health Organization. Timeline of WHO’s response to COVID-19. 2020 Jul 30 [cited 2020 Jul 31]. https://www.who.int/news-room/detail/29-06-2020-covidtimeline.
- COVID-19 Dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins university. 2020 Jul 31 [cited 2020 Jul 31]. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.
- World Health Organization. WHO coronavirus disease (COVID-19) dashboard. 2020 Jul 31 [cited 2020 Jul 31]. https://covid19.who.int/.
- Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients. MedRxiv. 2020.04.08.20058578. doi:https://doi.org/10.1101/2020.04.08.20058578.
- Undela K, Gudi SK. Assumptions for disparities in case-fatality rates of coronavirus disease (COVID-19) across the globe. Eur Rev Med Pharmacol Sci. 2020;24(9):5180–2. doi:https://doi.org/10.26355/eurrev_202005_21215.
- Zhao X, Zhang B, Li P, Ma C, Gu J, Hou P, Guo Z, Wu H, Bai Y. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020.03.17.20037572. doi:https://doi.org/10.1101/2020.03.17.20037572.
- Bikle D. Vitamin D: Production, metabolism, and mechanisms of action. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext (Internet). South Dartmouth (MA): MDText.com, Inc.; 2000. (76 pages). https://www.ncbi.nlm.nih.gov/books/NBK278935/.
- Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365–408. doi:https://doi.org/10.1152/physrev.00014.2015.
- Colotta F, Jansson B, Bonelli F. Modulation of inflammatory and immune responses by vitamin D. J Autoimmun. 2017;85:78–97. doi:https://doi.org/10.1016/j.jaut.2017.07.007.
- Li Y, Ding S. Serum 25-hydroxyvitamin D and the risk of mortality in adult patients with sepsis: a meta-analysis. BMC Infect Dis. 2020;20(1):189. doi:https://doi.org/10.1186/s12879-020-4879-1.
- Braun AB, Gibbons FK, Litonjua AA, Giovannucci E, Christopher KB. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med. 2012;40(1):63–72. doi:https://doi.org/10.1097/CCM.0b013e31822d74f3.
- Koivisto O, Hanel A, Carlberg C. Key vitamin D target genes with functions in the immune system. Nutrients. 2020;12(4):1140. doi:https://doi.org/10.3390/nu12041140.
- Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol. 2011;50(3):194–200. doi:https://doi.org/10.1016/j.jcv.2010.12.006.
- Leow L, Simpson T, Cursons R, Karalus N, Hancox RJ. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology. 2011;16(4):611–6. doi:https://doi.org/10.1111/j.1440-1843.2011.01924.x.
- Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids. 2013;78(2):127–36. doi:https://doi.org/10.1016/j.steroids.2012.10.019.
- Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf). 2012;76(3):315–25. doi:https://doi.org/10.1111/j.1365-2265.2011.04261.x.
- Parker LC, Prince LR, Sabroe I. Translational mini-review series on toll-like receptors: networks regulated by toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol. 2007;147(2):199–207. doi:https://doi.org/10.1111/j.1365-2249.2006.03203.x.
- Agier J, Brzezińska-Błaszczyk E, Żelechowska P, Wiktorska M, Pietrzak J, Różalska S. Cathelicidin LL-37 affects surface and intracellular toll-like receptor expression in tissue mast cells. J Immunol Res. 2018;2018:7357162. doi:https://doi.org/10.1155/2018/7357162.
- Lang PO, Aspinall R. Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response? Nutrients. 2015;7(3):2044–60. doi:https://doi.org/10.3390/nu7032044.
- Currie SM, Findlay EG, McHugh BJ, Mackellar A, Man T, Macmillan D, Wang H, Fitch PM, Schwarze J, Davidson DJ. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One. 2013;8(8):e73659. doi:https://doi.org/10.1371/journal.pone.0073659.
- Jain SK, Micinski D. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun. 2013;437(1):7–11. doi:https://doi.org/10.1016/j.bbrc.2013.06.004.
- Parsanathan R, Jain SK. Glutathione deficiency alters the vitamin D-metabolizing enzymes CYP27B1 and CYP24A1 in human renal proximal tubule epithelial cells and kidney of HFD-fed mice. Free Radic Biol Med. 2019;131:376–81. doi:https://doi.org/10.1016/j.freeradbiomed.2018.12.017.
- Ghezzi P. Role of glutathione in immunity and inflammation in the lung. Int J Gen Med. 2011;4:105–13. doi:https://doi.org/10.2147/IJGM.S15618.
- Jain SK, Parsanathan R, Achari AE, Kanikarla-Marie P, Bocchini JA. Jr. Glutathione stimulates vitamin D regulatory and glucose-metabolism genes, lowers oxidative stress and inflammation, and increases 25-hydroxy-vitamin D levels in blood: a novel approach to treat 25-hydroxyvitamin D deficiency. Antioxid Redox Signal. 2018;29(17):1792–807. doi:https://doi.org/10.1089/ars.2017.7462.
- Jain SK, Kanikarla-Marie P, Warden C, Micinski DL. L-cysteine supplementation upregulates glutathione (GSH) and vitamin D binding protein (VDBP) in hepatocytes cultured in high glucose and in vivo in liver, and increases blood levels of GSH, VDBP, and 25-hydroxy-vitamin D in Zucker diabetic fatty rats. Mol Nutr Food Res. 2016;60(5):1090–8. doi:https://doi.org/10.1002/mnfr.201500667.
- Jain SK, Manna P, Micinski D, Lieblong BJ, Kahlon G, Morehead L, Hoeldtke R, Bass PF, 3rd, Levine SN. In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of hydrogen sulfide and cyclic adenosine monophosphate, and elevated oxidative stress? Antioxid Redox Signal. 2013;18(10):1154–8. doi:https://doi.org/10.1089/ars.2012.4843.
- Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. doi:https://doi.org/10.1136/bmj.i6583.
- Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019;29(2):e2032. doi:https://doi.org/10.1002/rmv.2032.
- Gwyer Findlay E, Currie SM, Davidson DJ. Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs. 2013;27(5):479–93. doi:https://doi.org/10.1007/s40259-013-0039-0.
- Barlow PG, Beaumont PE, Cosseau C, Mackellar A, Wilkinson TS, Hancock RE, Haslett C, Govan JR, Simpson AJ, Davidson DJ. The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am J Respir Cell Mol Biol. 2010;43(6):692–702. doi:https://doi.org/10.1165/rcmb.2009-0250OC.
- Shartouny JR, Jacob J. Mining the tree of life: host defense peptides as antiviral therapeutics. Semin Cell Dev Biol. 2019;88:147–55. doi:https://doi.org/10.1016/j.semcdb.2018.03.001.
- Eckard AR, O'Riordan MA, Rosebush JC, Lee ST, Habib JG, Ruff JH, Labbato D, Daniels JE, Uribe-Leitz M, Tangpricha V, et al. Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther (Lond). 2018;23(4):315–24. doi:https://doi.org/10.3851/IMP3199.
- Schögler A, Muster RJ, Kieninger E, Casaulta C, Tapparel C, Jung A, Moeller A, Geiser T, Regamey N, Alves MP. Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37. Eur Respir J. 2016;47(2):520–30. doi:https://doi.org/10.1183/13993003.00665-2015.
- Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988. doi:https://doi.org/10.3390/nu12040988.
- Hu YC, Wang WW, Jiang WY, Li CQ, Guo JC, Xun YH. Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: a systematic review and meta-analysis. BMC Gastroenterol. 2019;19(1):84. doi:https://doi.org/10.1186/s12876-019-1004-2.
- Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol. 2013;58(1):184–9. doi:https://doi.org/10.1016/j.jhep.2012.07.026.
- Laplana M, Royo JL, Fibla J. Vitamin D receptor polymorphisms and risk of enveloped virus infection: a meta-analysis. Gene. 2018;678:384–94. doi:https://doi.org/10.1016/j.gene.2018.08.017.
- Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD, Greiffenstein P. Vitamin D insufficiency is prevalent in severe COVID-19. MedRxiv. 2020.04.24.20075838. doi:https://doi.org/10.1101/2020.04.24.20075838.
- Farrell SW, DeFina L, Willis B, Barlow CE, Pavlovic A, Leonard D, Haskell W. Cardiorespiratory fitness, different measures of adiposity, and serum vitamin D levels in African-American adults. J Investig Med. 2019;67(7):1087–90. doi:https://doi.org/10.1136/jim-2019-001071.
- Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991–2000. doi:https://doi.org/10.1056/NEJMoa1306357.
- Millett GA, Jones AT, Benkeser D, Baral S, Mercer L, Beyrer C, Honermann B, Lankiewicz E, Mena L, Crowley JS, et al. Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020;47:37–44. doi:https://doi.org/10.1016/j.annepidem.2020.05.003.
- DiMaggio D, Klein M, Berry C, Frangos S. Blacks/African Americans are 5 times more likely to develop COVID-19: spatial modeling of New York city ZIP code-level testing results. MedRxiv. 2020.05.14.20101691. doi:https://doi.org/10.1101/2020.05.14.20101691.
- Turk S. Racial disparities in Louisiana’s COVID-19 death rate reflect systemic problems. WWLTV.2020. 2020 Apr 27 [cited 2020 Jul 31]. https://www.wwltv.com/article/news/health/coronavirus/racial-disparities-in-louisianas-covid-19-death-rate-reflect-systemic-problems/289-bd36c4b1-1bdf-4d07-baad-6c3d207172f2.
- Jain SK, McVie R. Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism. 1994;43(3):306–9. doi:https://doi.org/10.1016/0026-0495(94)90097-3.
- Parsanathan R, Jain SK. Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice. Sci Rep. 2019;9(1):14784. doi:https://doi.org/10.1038/s41598-019-51377-5.
- Jain SK, Kahlon G, Bass P, Levine SN, Warden C. Can L-cysteine and vitamin D rescue vitamin D and vitamin D binding protein levels in blood plasma of African American type 2 diabetic patients? Antioxid Redox Signal. 2015;23(8):688–93. doi:https://doi.org/10.1089/ars.2015.6320.
- Jain SK, Micinski D, Huning L, Kahlon G, Bass PF, Levine SN. Vitamin D and L-cysteine levels correlate positively with GSH and negatively with insulin resistance levels in the blood of type 2 diabetic patients. Eur J Clin Nutr. 2014;68(10):1148–53. doi:https://doi.org/10.1038/ejcn.2014.114.
- Jain SK, Parsanathan R. Can vitamin D and L-cysteine co-supplementation reduce 25(OH)-vitamin D deficiency and the mortality associated with COVID-19 in African Americans? J Am Coll Nutr. 2020;39(8):1–6. doi:https://doi.org/10.1080/07315724.2020.1789518.
- Polonikov A. Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID-19 patients. ACS Infect Dis. 2020;6(7):1558–62. doi:https://doi.org/10.1021/acsinfecdis.0c00288.
- Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer-Pietsch B, Bianchi ML, Stepan J, El-Hajj Fuleihan G, Bouillon R. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European calcified tissue society. Eur J Endocrinol. 2019;180(4):P23–P54. doi:https://doi.org/10.1530/EJE-18-0736.
- Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020;32(7):1195–4. doi:https://doi.org/10.1007/s40520-020-01570-8.
- Laird E, Kenny RA. Vitamin D deficiency in Ireland - implications for COVID-19. Results from the Irish longitudinal study on ageing (TILDA). [cited 2020 Jul 31]. https://tilda.tcd.ie/publications/reports/pdf/Report_Covid19VitaminD.pdf.
- Moozhipurath RK, Kraft L, Skiera B. Evidence of protective role of ultraviolet-B (UVB) radiation in reducing COVID-19 deaths. MedRxiv. 2020.05.06.20093419. doi:https://doi.org/10.1101/2020.05.06.20093419.
- Baggett TP, Keyes H, Sporn N, Gaeta JM. COVID-19 outbreak at a large homeless shelter in Boston: implications for universal testing. MedRxiv. 2020.04.12.20059618. doi:https://doi.org/10.1101/2020.04.12.20059618.
- American Society of Hematology. COVID-19 and coagulopathy: frequently asked questions. COVID-19 resources. 2020 May 18 [cited 2020 May 18]. https://www.hematology.org/covid-19/covid-19-and-coagulopathy.
- Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440. doi:https://doi.org/10.1016/S2352-3026(20)30145-9.
- Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–8. doi:https://doi.org/10.1016/j.cca.2020.03.022.
- Argacha JF, Egrise D, Pochet S, Fontaine D, Lefort A, Libert F, Goldman S, van de Borne P, Berkenboom G, Moreno-Reyes R. Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression. J Cardiovasc Pharmacol. 2011;58(1):65–71. doi:https://doi.org/10.1097/FJC.0b013e31821c832f.
- Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, Zakri I, Sabai A, Darraj M, Mutawwam DA, et al. Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan city, Saudi Arabia. Diabetes Metab Syndr Obes. 2019;12:853–62. doi:https://doi.org/10.2147/DMSO.S203700.
- Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. 2020;323(18):1769–70. doi:https://doi.org/10.1001/jama.2020.4812.
- Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7. doi:https://doi.org/10.1002/path.1570.
- Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. 2020.01.31.929042. doi:https://doi.org/10.1101/2020.01.31.929042.
- Bajwa EK, Bhan I, Quraishi S, Matthay M, Thompson BT. Vitamin D status occurs in 90% of patients with ARDS and is associated with longer duration of mechanical ventilation. Am J Respir Crit Care Med. 2016;193:A1846. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A1846
- Shi Y, Liu T, Yao L, Xing Y, Zhao X, Fu J, Xue X. Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system. Sci Rep. 2017;7(1):1–10. doi:https://doi.org/10.1038/s41598-017-03474-6.
- Glicio EJ. Vitamin D level of mild and severe elderly cases of COVID-19: a preliminary report. SSRN. 2020 [cited 2020 Jul 31]. https://ssrn.com/abstract=3593258.
- Raharusuna P, Priambada S, Budiarti C, Agung E, Budi C. Patterns of COVID-19 mortality and Vitamin D: an Indonesian study. SSRN. 2020 [cited 2020 Jul 31]. https://ssrn.com/abstract=3585561. doi:https://doi.org/10.2139/ssrn.3585561.
- D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, Keller F, Cantù M. 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients. 2020;12(5):1359. doi:https://doi.org/10.3390/nu12051359.
- Laird E, Rhodes J, Kenny RA. Vitamin D and inflammation: potential implications for severity of covid-19. Ir Med J. 2020;113(5):P81.
- Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D deficiency and treatment with COVID-19 incidence. MedRxiv. 2020.05.08.20095893. doi:https://doi.org/10.1101/2020.05.08.20095893.
- Alipio MM. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus-2019 (COVID-19). SSRN. 2020. doi:https://doi.org/10.2139/ssrn.3571484.
- Herwig R, Panhofer TP, Greilberger M, Greilberger J. Sedeprovid, a novel vitamin D based substance, plus AlphaH℗ lead to complete recovery from COVID-19 within 48 hours after application in a 7-months old baby, a 1.5-year-old toddler and three further adults. J Transl Sci. 2020;7:1–10. doi:https://doi.org/10.15761/JTS.1000385.
- Sun JK, Zhang WH, Zou L, Liu Y, Li JJ, Kan XH, Dai L, Shi QK, Yuan ST, Yu WK, et al. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging. 2020;12(12):11287–95. doi:https://doi.org/10.18632/aging.103526.
- Lansiaux E, Pébaÿ PP, Picard J-L, Son-Forget J. Covid-19 and vit-D: disease mortality negatively correlates with sunlight exposure. Spatio-Temporal Epidemiol. 2020;35. doi:https://doi.org/10.1016/j.sste.2020.100362.
- Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, Jani BD, Welsh P, Mair FS, Gray SR, et al. Vitamin D concentrations and COVID-19 Infection in UK biobank. Diabetes Metab Syndr. 2020;14(4):561–5. doi:https://doi.org/10.1016/j.dsx.2020.04.050.
- Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282(41):29821–30. doi:https://doi.org/10.1074/jbc.M705495200.
- Grant WB, Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinol. 2009;1(4):215–9. doi:https://doi.org/10.4161/derm.1.4.9063.
- Davies G, Garami AR, Byers J. Evidence supports a causal model for vitamin D in COVID-19 outcomes. MedRxiv. 2020.05.01.20087965. doi:https://doi.org/10.1101/2020.05.01.20087965.
- United Kingdom National Health Service. Vitamin and minerals-vitamin D. [cited 2020 Jul 30]. https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/.
- Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8. doi:https://doi.org/10.1210/jc.2010-2704.
- Ebadi M, Montano-Loza AJ. Perspective: improving vitamin D status in the management of COVID-19. Eur J Clin Nutr. 2020;74(6):856–4. doi:https://doi.org/10.1038/s41430-020-0661-0.
- Wimalawansa SJ. Global epidemic of coronavirus- COVID-19: what can we do to minimize risks. Eur J Biomed Pharm Sci. 2020;7(3):432–8.
- Lewis RD, Laing EM. Conflicting reports on vitamin D supplementation: evidence from randomized controlled trials. Mol Cell Endocrinol. 2015;410:11–8. doi:https://doi.org/10.1016/j.mce.2015.03.017.
- Lin KW. Vitamin D screening and supplementation in primary care: time to curb our enthusiasm. Am Fam Physician. 2018;97(4):226–7.
- Lanham-New SA, Webb AR, Cashman KD, Buttriss JL, Fallowfield JL, Masud T, Hewison M, Mathers JC, Kiely M, Welch AA, et al. Vitamin D and SARS-CoV-2 virus/COVID-19 disease. BMJ Nutr Prev Health. 2020;3(1):106–10. doi:https://doi.org/10.1136/bmjnph-2020-000089.
- Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D toxicity-a clinical perspective. Front Endocrinol (Lausanne)). 2018;9:550. doi:https://doi.org/10.3389/fendo.2018.00550.